Literature DB >> 19190162

Risk factors for pancreatic cancer mortality: extended follow-up of the original Whitehall Study.

G David Batty1, Mika Kivimaki, David Morrison, Rachel Huxley, George Davey Smith, Robert Clarke, Michael G Marmot, Martin J Shipley.   

Abstract

Given the well-established links between diabetes and elevated rates of pancreatic cancer, there are reasons to anticipate that other markers of metabolic abnormality (increased body mass index, plasma cholesterol, and blood pressure) and their correlates (physical activity and socioeconomic status) may also confer increased risk. However, to date, the results of a series of population-based cohort studies are inconclusive. We examined these associations in the original Whitehall cohort study of 17,898 men. A maximum of 38 years of follow-up gave rise to 163 deaths due to carcinoma of the pancreas. Although Poisson regression analyses confirmed established risk factor-disease associations for increasing age, smoking, and type II diabetes, there was essentially no evidence that body mass index (rate ratio, 1.01; 95% confidence interval per 1 SD increase, 0.86-1.18), plasma cholesterol (0.91; 0.78-1.07), diastolic blood pressure (0.93; 0.78-1.09), systolic blood pressure (0.98; 0.83-1.15), physical activity (sedentary versus high: 1.37; 0.89-2.12), or socioeconomic status [clerical (low) versus professional/executive, 0.95; 0.59-1.51] offered any predictive value for pancreatic cancer mortality. These results were unchanged following control for a range of covariates.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19190162      PMCID: PMC3226943          DOI: 10.1158/1055-9965.EPI-08-1032

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  29 in total

1.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

Review 2.  Risk factors for pancreatic cancer.

Authors:  Albert B Lowenfels; Patrick Maisonneuve
Journal:  J Cell Biochem       Date:  2005-07-01       Impact factor: 4.429

3.  A prospective study of lifestyle factors and the risk of pancreatic cancer in Nord-Trøndelag, Norway.

Authors:  T I Nilsen; L J Vatten
Journal:  Cancer Causes Control       Date:  2000-08       Impact factor: 2.506

4.  The effect of modifiable risk factors on pancreatic cancer mortality in populations of the Asia-Pacific region.

Authors:  Alireza Ansary-Moghaddam; Rachel Huxley; Federica Barzi; Carlene Lawes; Takayoshi Ohkubo; Xianghua Fang; Sun Ha Jee; Mark Woodward
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-12       Impact factor: 4.254

5.  The association of blood pressure with cancer incidence in a prospective study.

Authors:  J S Grove; A Nomura; R K Severson; G N Stemmermann
Journal:  Am J Epidemiol       Date:  1991-11-01       Impact factor: 4.897

Review 6.  Pancreatic cancer.

Authors:  Donghui Li; Keping Xie; Robert Wolff; James L Abbruzzese
Journal:  Lancet       Date:  2004-03-27       Impact factor: 79.321

7.  Socioeconomic differentials in cancer among men.

Authors:  G D Smith; D Leon; M J Shipley; G Rose
Journal:  Int J Epidemiol       Date:  1991-06       Impact factor: 7.196

8.  Plasma cholesterol concentration and mortality. The Whitehall Study.

Authors:  G D Smith; M J Shipley; M G Marmot; G Rose
Journal:  JAMA       Date:  1992-01-01       Impact factor: 56.272

9.  Adult height in relation to mortality from 14 cancer sites in men in London (UK): evidence from the original Whitehall study.

Authors:  G D Batty; M J Shipley; C Langenberg; M G Marmot; G Davey Smith
Journal:  Ann Oncol       Date:  2005-10-25       Impact factor: 32.976

10.  Magnitude and causes of mortality differences between married and unmarried men.

Authors:  Y Ben-Shlomo; G D Smith; M Shipley; M G Marmot
Journal:  J Epidemiol Community Health       Date:  1993-06       Impact factor: 3.710

View more
  20 in total

Review 1.  Obesity and pancreatic cancer: overview of epidemiologic evidence and biologic mechanisms.

Authors:  Paige M Bracci
Journal:  Mol Carcinog       Date:  2012-01       Impact factor: 4.784

2.  Multi-institutional analysis of pancreatic adenocarcinoma demonstrating the effect of diabetes status on survival after resection.

Authors:  Robert M Cannon; Ryan LeGrand; Ryaz B Chagpar; Syed A Ahmad; Rebecca McClaine; Hong Jin Kim; Christopher Rupp; Cliff S Cho; Adam Brinkman; Sharon Weber; Emily R Winslow; David A Kooby; Carrie K Chu; Charles A Staley; Ian Glenn; William G Hawkins; Alexander A Parikh; Nipun B Merchant; Kelly M McMasters; Robert C G Martin; Glenda G Callender; Charles R Scoggins
Journal:  HPB (Oxford)       Date:  2012-01-19       Impact factor: 3.647

Review 3.  Physical activity and risk of pancreatic cancer: a systematic review and meta-analysis.

Authors:  Gundula Behrens; Carmen Jochem; Daniela Schmid; Marlen Keimling; Cristian Ricci; Michael F Leitzmann
Journal:  Eur J Epidemiol       Date:  2015-03-15       Impact factor: 8.082

Review 4.  Diabetes and cancer (2): evaluating the impact of diabetes on mortality in patients with cancer.

Authors:  A G Renehan; H-C Yeh; J A Johnson; S H Wild; E A M Gale; H Møller
Journal:  Diabetologia       Date:  2012-04-04       Impact factor: 10.122

5.  Carcinoma pancreas.

Authors:  K J Singh; Ashwin Galagali; G Menon
Journal:  Med J Armed Forces India       Date:  2012-07

Review 6.  Premorbid Obesity and Mortality in Patients With Pancreatic Cancer: A Systematic Review and Meta-analysis.

Authors:  Kaustav Majumder; Arjun Gupta; Nivedita Arora; Preet Paul Singh; Siddharth Singh
Journal:  Clin Gastroenterol Hepatol       Date:  2015-10-14       Impact factor: 11.382

7.  High glucose promotes cell proliferation and enhances GDNF and RET expression in pancreatic cancer cells.

Authors:  Han Liu; Qingyong Ma; Junhui Li
Journal:  Mol Cell Biochem       Date:  2010-10-20       Impact factor: 3.396

8.  Medically managed hypercholesterolemia and insulin-dependent diabetes mellitus preoperatively predicts poor survival after surgery for pancreatic cancer.

Authors:  Ryaz B Chagpar; Robert C G Martin; Syed A Ahmad; Hong Jin Kim; Christopher Rupp; Sharon Weber; Andrew Ebelhar; Juliana Gilbert; Adam Brinkman; Emily Winslow; Clifford S Cho; David Kooby; Carrie K Chu; Charles A Staley; Kelly M McMasters; Charles R Scoggins
Journal:  J Gastrointest Surg       Date:  2011-02-15       Impact factor: 3.452

9.  A pooled analysis of body mass index and pancreatic cancer mortality in african americans.

Authors:  Traci N Bethea; Cari M Kitahara; Jennifer Sonderman; Alpa V Patel; Chinonye Harvey; Synnøve F Knutsen; Yikyung Park; Song Yi Park; Gary E Fraser; Eric J Jacobs; Mark P Purdue; Rachael Z Stolzenberg-Solomon; Elizabeth M Gillanders; William J Blot; Julie R Palmer; Laurence N Kolonel
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-07-13       Impact factor: 4.254

10.  Diabetes and risk of pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium.

Authors:  Joanne W Elena; Emily Steplowski; Kai Yu; Patricia Hartge; Geoffrey S Tobias; Michelle J Brotzman; Stephen J Chanock; Rachael Z Stolzenberg-Solomon; Alan A Arslan; H Bas Bueno-de-Mesquita; Kathy Helzlsouer; Eric J Jacobs; Andrea LaCroix; Gloria Petersen; Wei Zheng; Demetrius Albanes; Naomi E Allen; Laufey Amundadottir; Ying Bao; Heiner Boeing; Marie-Christine Boutron-Ruault; Julie E Buring; J Michael Gaziano; Edward L Giovannucci; Eric J Duell; Göran Hallmans; Barbara V Howard; David J Hunter; Amy Hutchinson; Kevin B Jacobs; Charles Kooperberg; Peter Kraft; Julie B Mendelsohn; Dominique S Michaud; Domenico Palli; Lawrence S Phillips; Kim Overvad; Alpa V Patel; Leah Sansbury; Xiao-Ou Shu; Michael S Simon; Nadia Slimani; Dimitrios Trichopoulos; Kala Visvanathan; Jarmo Virtamo; Brian M Wolpin; Anne Zeleniuch-Jacquotte; Charles S Fuchs; Robert N Hoover; Myron Gross
Journal:  Cancer Causes Control       Date:  2012-10-31       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.